Data / New clinical trials / Endometrial Neoplasms

Endometrial Neoplasms trials: 261 new since Nov 2024

Name: New Endometrial Neoplasms clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Endometrial Neoplasms clinical trials: 261 rows for $13.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 13 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/endometrial-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 4, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

261 clinical studies in Endometrial Neoplasms were first posted on ClinicalTrials.gov from November 13, 2024 to November 4, 2026; 91 have an industry sponsor and 220 are recruiting or about to. The newest, NCT07916610, was posted on November 4, 2026: Comparison of Superficial-Only Versus Combined Indocyanine Green Injection Techniques for Sentinel Lymph Node... (Barretos Cancer Hospital).

The request: Every new Endometrial Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

261New trials
91Industry sponsored
220Recruiting or not yet
November 4, 2026Latest posted

Newest trials

The newest 100 of 261, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 4, 2026	NCT07916610	Comparison of Superficial-Only Versus Combined Indocyanine Green Injection Techniques for Sentinel Lymph Node Mapping in Patients With...	Barretos Cancer Hospital	Not applicable	Not yet recruiting	Endometrial Cancer	200		clinicaltrials.gov
November 2, 2026	NCT07909031	CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors	Crescent Biopharma, Inc.	Phase 1/2	Recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)...	219	United States	clinicaltrials.gov
October 28, 2026	NCT07902375	Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers	Universiteit Antwerpen	Not applicable	Recruiting	Gynaecological Cancers, Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Postmenopausal Bleeding...	730	Belgium	clinicaltrials.gov
October 28, 2026	NCT07900256	A Preliminary Exploratory Study of Cadonilimab Combined With Progestin for Fertility-Sparing Treatment in Early Endometrial Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2	Not yet recruiting	Endometrial Cancer	10		clinicaltrials.gov
October 27, 2026	NCT07896720	Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study	Women's Hospital School Of Medicine Zhejiang University	Not applicable	Not yet recruiting	Endometrial Cancer, Cervical Cancer (Early Detection)	92		clinicaltrials.gov
October 26, 2026	NCT07895212	Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Not applicable	Recruiting	Ovary Cancer, Cervical Cancer, Endometrial Cancer	40	China	clinicaltrials.gov
October 23, 2026	NCT07892755	Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese Populations	Guizhou Provincial People's Hospital	Observational	Recruiting	Endometrial Cancer, Atypical Endometrial Hyperplasia	512	China	clinicaltrials.gov
October 20, 2026	NCT07883798	Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions	Affidea Nu-med Center of Oncological DIagnostics and Therapy	Observational	Recruiting	Cervical Cancer, Gynecologic Cancer, Endometrial Cancer, Uterine Cancer, Uterine Sarcoma, Ovarian Cancer, Fallopian...	500	Poland	clinicaltrials.gov
October 20, 2026	NCT07882277	27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery	Metehan Uzundal	Not applicable	Not yet recruiting	Endometrial Cancer	70	Turkey (Türkiye)	clinicaltrials.gov
October 16, 2026	NCT07879365	Effect of Weight Management on AMPK Activation in the Adjunctive Treatment of Endometrial Cancer	Peking University People's Hospital	Not applicable	Not yet recruiting	Endometrial Cancer	160	China	clinicaltrials.gov
October 16, 2026	NCT07877779	Protocol for Non-invasive Gynaecological Surveillance in Lynch Syndrome	University of Edinburgh	Observational	Not yet recruiting	Lynch Syndrome	1,450	United Kingdom	clinicaltrials.gov
October 15, 2026	NCT07874880	MTX-531-001 Phase 1 Study in Advanced Solid Tumors	MEKanistic Therapeutics, Inc.	Phase 1	Not yet recruiting	Solid Tumors (Phase 1), HNSCC, Endometrial Cancer, Her2-negative Metastatic Breast Cancer, Pan-RAS and BRAF Wild-type...	71	United States	clinicaltrials.gov
October 15, 2026	NCT07874529	Cervical Cytology DNA Methylation for Endometrial Cancer Screening	Lei Li	Observational	Active not recruiting	Endometrial Cancer, DNA Methylation, Cytology, Cancer Screening	30,000	China	clinicaltrials.gov
October 13, 2026	NCT07871838	Safety, Efficacy and Quality of Life After Adjuvant Hypofractionated Radiotherapy for Endometrial Cancer	McGill University Health Centre/Research Institute of the McGill University Health Centre	Not applicable	Recruiting	Endometrial Cancer, Endometrial Adenocarcinoma	50	Canada	clinicaltrials.gov
October 13, 2026	NCT07870278	A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)	Merck Sharp & Dohme LLC	Phase 1	Not yet recruiting	Ovarian Neoplasms, Endometrial Neoplasms	80		clinicaltrials.gov
October 9, 2026	NCT07867002	Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer	UNC Lineberger Comprehensive Cancer Center	Phase 3	Recruiting	Endometrial Adenocarcinoma, Metastatic Endometrial Cancer, Endometrial Cancer, Recurrent Endometrial Cancer	140	United States	clinicaltrials.gov
October 8, 2026	NCT07865650	PEG-rhG-CSF Primary Prophylaxis vs Therapeutic Short-Acting rhG-CSF for Neutropenia During Pelvic Chemoradiotherapy in Cervical or...	The Second Hospital of Anhui Medical University	Not applicable	Active not recruiting	Cervical Cancer, Endometrial Cancer	90	China	clinicaltrials.gov
October 6, 2026	NCT07860450	Two Part (Phase1b/ Phase3) Trial of Subcutaneous Dostarlimab Plus Carboplatin-Paclitaxel in Participants With Primary Advanced or Recurrent...	GlaxoSmithKline	Phase 3	Not yet recruiting	Endometrial Carcinoma, Neoplasms, Endometrial	378		clinicaltrials.gov
October 6, 2026	NCT07860203	Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery	Catherin Zhang	Not applicable	Recruiting	Uterine Fibroids (Leiomyoma), Adenomyosis of Uterus, Endometriosis, Endometrial Cancer, Cervical Cancer, Ovarian Cancer	100	China	clinicaltrials.gov
September 24, 2026	NCT07838207	Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer	Hospital Universitari Vall d'Hebron Research Institute	Observational	Recruiting	Endometrial Cancer, Endometrial Carcinoma (EC), p53abn	350	Spain	clinicaltrials.gov
September 21, 2026	NCT07832227	Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial	Dana-Farber Cancer Institute	Phase 2	Not yet recruiting	Low Grade Ovarian Serous Adenocarcinoma, Endometrial Cancer	60		clinicaltrials.gov
September 21, 2026	NCT07831902	Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With...	University College, London	Phase 3	Recruiting	Endometrial Cancer, Uterine Neoplasms	600	United Kingdom	clinicaltrials.gov
September 16, 2026	NCT07821775	Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers	Asan Medical Center	Observational	Completed	Pancreatic Neoplasms, Stomach Neoplasms, Rectal Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms, Kidney...	32,949	South Korea	clinicaltrials.gov
September 15, 2026	NCT07820358	Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer	The Methodist Hospital Research Institute	Phase 2	Not yet recruiting	Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial...	48	United States	clinicaltrials.gov
September 11, 2026	NCT07815951	Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors	Yong He	Phase 1	Not yet recruiting	Solid Tumors, Carcinoma, Ovarian Neoplasms, Endometrial Neoplasms Malignant, Testicular Neoplasms, Lung Neoplasms...	8	China	clinicaltrials.gov
September 11, 2026	NCT07815873	Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers	European Institute of Oncology	Not applicable	Not yet recruiting	Non Small Cell Lung Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Cervical Cancer	360	Italy	clinicaltrials.gov
September 11, 2026	NCT07814872	A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment	Harvard Medical School (HMS and HSDM)	Observational	Not yet recruiting	Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic...	30,000	United States	clinicaltrials.gov
September 10, 2026	NCT07814248	A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a...	TwoStep Therapeutics, Inc.	Phase 1	Recruiting	NSCLC (Non-small Cell Lung Cancer), HNSCC, Endometrial, Ovarian Cancer, Esophageal Cancer, Head & Neck Cancer, Gastric...	74	United States	clinicaltrials.gov
September 10, 2026	NCT07811297	A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers	Advenchen Pharmaceuticals, LLC.	Phase 1/2	Not yet recruiting	Endometrial Neoplasms, Ovarian Neoplasms, Soft Tissue Sarcoma (STS), Glioblastoma	138	United States	clinicaltrials.gov
September 10, 2026	NCT07811232	A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers	Advenchen Pharmaceuticals, LLC.	Phase 1/2	Not yet recruiting	Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms	138	United States	clinicaltrials.gov
September 8, 2026	NCT07808164	ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort	Tam Anh Research Institute	Observational	Recruiting	HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial...	162	Vietnam	clinicaltrials.gov
September 8, 2026	NCT07807345	Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic	Sutro Biopharma, Inc.	Phase 1	Recruiting	Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Colorectal Cancer...	285	United States	clinicaltrials.gov
August 28, 2026	NCT07793318	TR115 in ARID1A-Mutated Advanced Solid Tumors	Tarapeutics Science Inc.	Phase 2	Not yet recruiting	Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent, Urinary Bladder Cancer	50	China	clinicaltrials.gov
August 24, 2026	NCT07781150	Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer	Tongji Hospital	Phase 2	Not yet recruiting	Obesity, Overweight, Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I, Endometrioid Endometrial Cancer	128	China	clinicaltrials.gov
August 21, 2026	NCT07779109	Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)	Instituto de Investigación Sanitaria Aragón	Not applicable	Recruiting	SBRT, Radiation Therapy, Endometrial Cancer, Endometrial Cancer Stage III, High-risk Endometrial Cancer	50	Spain	clinicaltrials.gov
August 10, 2026	NCT07755436	Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic...	ArriVent BioPharma, Inc.	Phase 1	Recruiting	Ovarian Cancer, Endometrial Cancer, Platinum-resistant Ovarian Cancer (PROC), Metastatic Ovarian Cancer, Metastatic...	180	United States	clinicaltrials.gov
August 7, 2026	NCT07752875	A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation	LG Chem	Phase 1/2	Not yet recruiting	Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Esophageal Cancer, Breast...	250		clinicaltrials.gov
August 4, 2026	NCT07746024	Advancing Risk Stratification in Endometrial Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Active not recruiting	Endometrial Cancer	400	Italy	clinicaltrials.gov
August 4, 2026	NCT07743541	Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy	Gilead Sciences	Phase 1/2	Not yet recruiting	Uterine Endometrial Cancer	100	United States	clinicaltrials.gov
August 3, 2026	NCT07741968	A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer	City of Hope Medical Center	Not applicable	Recruiting	Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC...	126	United States	clinicaltrials.gov
July 31, 2026	NCT07739745	Development Of An Endometrial Cancer Educational Tool	M.D. Anderson Cancer Center	Not applicable	Not yet recruiting	Endometrial Cancer	250	United States	clinicaltrials.gov
July 31, 2026	NCT07738315	Elemene Liposomes in Endometrial Cancer	Women's Hospital School Of Medicine Zhejiang University	Phase 2	Not yet recruiting	Endometrial Carcinoma	212	China	clinicaltrials.gov
July 30, 2026	NCT07737795	Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer	University of Oklahoma	Phase 2	Not yet recruiting	Endometrial Cancer	66	United States	clinicaltrials.gov
July 28, 2026	NCT07731607	Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer	Wang Jianliu	Phase 2	Not yet recruiting	MMRd Endometrial Cancer of Stage I~II	48		clinicaltrials.gov
July 24, 2026	NCT07725159	Comparison of Lee-Huang Point and Umbilical Entry for Laparoscopic Success in Endometrial Cancer Patients	Dr. Lutfi Kirdar Kartal Training and Research Hospital	Not applicable	Completed	Endometrial Cancer	202	Turkey (Türkiye)	clinicaltrials.gov
July 23, 2026	NCT07723235	Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and...	Ohio State University Comprehensive Cancer Center	Not applicable	Not yet recruiting	Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC...	90	United States	clinicaltrials.gov
July 20, 2026	NCT07715747	A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors	TJ Biopharma Co., Ltd.	Phase 1	Recruiting	Solid Tumor, Metastatic Ovary Cancer, Metastatic Gastric Cancer, Metastatic Endometrial Carcinoma	128	China	clinicaltrials.gov
July 20, 2026	NCT07714070	Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia	Peking University People's Hospital	Phase 2	Not yet recruiting	Endometrial Neoplasms, Endometrial Cancer, Atypical Endometrial Hyperplasia, Progestin Resistance	48	China	clinicaltrials.gov
July 14, 2026	NCT07702799	Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer	Mahmut Yassa	Not applicable	Recruiting	Endometrial Cancer	100	Turkey (Türkiye)	clinicaltrials.gov
July 14, 2026	NCT07702721	Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Gynecologic Cancer, Cervical Cancer, Endometrial Cancer, Ovary Cancer, Vulvar Cancer	160		clinicaltrials.gov
July 8, 2026	NCT07690540	DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER	European Institute of Oncology	Not applicable	Recruiting	Endometrial Cancer, Immune Checkpoint Inhibitors	510	Italy	clinicaltrials.gov
July 6, 2026	NCT07684599	A Study to Investigate Mocertatug Rezetecan as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)	GlaxoSmithKline	Phase 3	Recruiting	Neoplasms, Endometrial	610	Canada, Japan, South Korea	clinicaltrials.gov
July 2, 2026	NCT07681414	ctDNA Assessment in Endometrial Cancer for Adjuvant Therapy	Guizhou Provincial People's Hospital	Observational	Active not recruiting	Endometrial Cancer	52	China	clinicaltrials.gov
June 30, 2026	NCT07675733	A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability...	Royal Marsden NHS Foundation Trust	Not applicable	Recruiting	Endometrial Carcinoma (EC)	30	United Kingdom	clinicaltrials.gov
June 24, 2026	NCT07664735	A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.	Outpace Bio, Inc.	Phase 1	Recruiting	Endometrial Cancer Recurrent, Endometrial Cancer, Advanced Endometrial Cancer, Ovarian Cancer, Ovarian Cancer...	30	United States	clinicaltrials.gov
June 23, 2026	NCT07662824	Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy	Mayo Clinic	Not applicable	Recruiting	Cervical Carcinoma, Endometrial Carcinoma, Overactive Bladder, Voiding Disorders	44	United States	clinicaltrials.gov
June 17, 2026	NCT07652515	A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer	GlaxoSmithKline	Phase 4	Not yet recruiting	Neoplasms, Endometrial	100		clinicaltrials.gov
June 11, 2026	NCT07643012	Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer	Rutgers, The State University of New Jersey	Not applicable	Recruiting	Endometrial Cancer	30	United States	clinicaltrials.gov
June 10, 2026	NCT07639801	68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors	Peking University Cancer Hospital & Institute	Not applicable	Not yet recruiting	Prostate Cancer, Hepatocellular Carcinoma, Ovarian Cancer, Solid Tumors, Endometrial Cancer, FAPI, PSMA	20		clinicaltrials.gov
June 9, 2026	NCT07634601	Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer	Jonsson Comprehensive Cancer Center	Phase 2	Not yet recruiting	Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Stage III...	50	United States	clinicaltrials.gov
June 8, 2026	NCT07631884	Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor	Haihua Yuan	Phase 2	Not yet recruiting	Solid Tumors, Neoplasms (Cancer / Tumors), Advanced Malignant Solid Neoplasm, Locally Advanced Malignant Solid...	15		clinicaltrials.gov
June 8, 2026	NCT07631871	An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy	Haihua Yuan	Phase 2	Not yet recruiting	Neoplasms, Solid Tumors, HER2 Positive Solid Tumor, Endometrial Neoplasm, Urothelial Carcinoma (UC), Pancreatic...	10		clinicaltrials.gov
June 3, 2026	NCT07623369	A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors	Huahui Health	Phase 1	Recruiting	Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Head and Neck Squamous Cell...	299	Australia, China	clinicaltrials.gov
June 3, 2026	NCT07622901	Fasting InTervention for Endometrial Cancer	University of Miami	Not applicable	Recruiting	Endometrial Cancer	42	United States	clinicaltrials.gov
May 29, 2026	NCT07612891	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With...	Shenzhen Ionova Life Sciences Co., Ltd.	Phase 1/2	Recruiting	Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer, Ovarian...	201	China	clinicaltrials.gov
May 28, 2026	NCT07610798	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced...	Shenzhen Ionova Life Sciences Co., Ltd.	Phase 1/2	Recruiting	Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC, Pancreatic Adenocarcinoma Advanced...	178	China	clinicaltrials.gov
May 22, 2026	NCT07605247	Tirzepatide in the Treatment of Endometrial Cancer	Rutgers, The State University of New Jersey	Phase 2	Not yet recruiting	Endometrial Cancer	30		clinicaltrials.gov
May 19, 2026	NCT07595224	Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer	Siriraj Hospital	Not applicable	Recruiting	Endometrial Cancer, Cervix Cancer	120	Thailand	clinicaltrials.gov
May 18, 2026	NCT07594327	Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer	Tampere University Hospital	Observational	Enrolling by invitation	Cervical Cancers, Vaginal Cancers, Vulvar Cancers, Endometrial Cancer, Gynecologic Cancers	21	Finland	clinicaltrials.gov
May 18, 2026	NCT07594015	Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line...	University of Miami	Phase 2	Recruiting	Recurrent Endometrial Cancer	46	United States	clinicaltrials.gov
May 14, 2026	NCT07586826	Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or...	Peking University People's Hospital	Phase 2	Recruiting	Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers...	220	China	clinicaltrials.gov
May 13, 2026	NCT07584161	MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer	Xiaorong Hou	Not applicable	Recruiting	Cervical Cancer, Endometrial Cancer	228	China	clinicaltrials.gov
May 13, 2026	NCT07583329	Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic...	Cukurova University	Observational	Not yet recruiting	Endometrial Adenocarcinoma, Endometrial Cancer	160	Turkey (Türkiye)	clinicaltrials.gov
May 12, 2026	NCT07581288	Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression	University of British Columbia	Observational	Not yet recruiting	Uterine Bleeding, Uterine Cancer, Uterine Neoplasms, Endometrial Cancer, Endometrial Hyperplasia, Endometrial...	50	Canada	clinicaltrials.gov
May 11, 2026	NCT07578649	Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With...	Pfizer	Phase 3	Recruiting	Endometrial Neoplasms, Endometrial Cancer	600	Australia, China, Japan, Taiwan, United States	clinicaltrials.gov
April 30, 2026	NCT07558889	The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Recruiting	Endometrium Cancer, Gynecologic Cancer	10,000	Italy	clinicaltrials.gov
April 29, 2026	NCT07557225	18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors	Peking University First Hospital	Not applicable	Recruiting	Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer, Ovarian Cancer...	200	China	clinicaltrials.gov
April 29, 2026	NCT07555665	REal Word aPpLicAtion of Molecular Based Endometrial Cancer Classification	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Recruiting	Endometrial Cancer	264	Italy	clinicaltrials.gov
April 22, 2026	NCT07544680	Endometrial Cancer Vaginal Fluid Specimen Collection Study	Exact Sciences Corporation	Observational	Active not recruiting	Abnormal Uterine Bleeding (AUB), Endometrial Cancer, Atypical Endometrial Hyperplasia, Endometrial Hyperplasia With...	4,200	United States	clinicaltrials.gov
April 14, 2026	NCT07527143	Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer	Mayo Clinic	Observational	Recruiting	Endometrial Carcinoma	25	United States	clinicaltrials.gov
April 13, 2026	NCT07524322	Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors	Regor Pharmaceuticals Inc.	Phase 1	Recruiting	Breast Cancer, Ovarian Cancer, Endometrial Cancer, PIK3CA Mutation, HER2- Negative Breast Cancer, Advanced Breast...	63	United States	clinicaltrials.gov
April 13, 2026	NCT07522697	Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4	National Cancer Institute, Naples	Phase 2	Not yet recruiting	Endometrial Cancer	48	Italy	clinicaltrials.gov
April 7, 2026	NCT07516210	Adaptive Radiotherapy for Safe Hypofractionation	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2	Not yet recruiting	Cancer, Endometrial Cancer, Prostate Cancer, Cervical Cancer, Rectal Cancers	264	Canada	clinicaltrials.gov
April 7, 2026	NCT07514325	MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer	Radboud University Medical Center	Not applicable	Not yet recruiting	Endometrial Cancer, Radiotherapy, Adjuvant	61		clinicaltrials.gov
March 31, 2026	NCT07503808	A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types	IDEAYA Biosciences	Phase 1	Recruiting	Esophageal Squamous Cell Carcinoma, High Grade Serous Ovarian Cancer, Head and Neck Squamous Cell Carcinoma, Colorectal...	150	United States	clinicaltrials.gov
March 13, 2026	NCT07470853	A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.	Whitehawk Therapeutics, Inc.	Phase 1	Recruiting	PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer	265	United States	clinicaltrials.gov
March 10, 2026	NCT07462663	SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage...	Hospital Universitari de Bellvitge	Phase 4	Not yet recruiting	Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I...	80		clinicaltrials.gov
March 9, 2026	NCT07458347	A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral...	Kestrel Therapeutics, Inc.	Phase 1	Recruiting	KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant...	545	United States	clinicaltrials.gov
March 6, 2026	NCT07453394	QLS5132 Combination Therapy in Advanced Solid Tumors	Qilu Pharmaceutical Co., Ltd.	Phase 1/2	Not yet recruiting	Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC), Endometrial Cancer, Advanced Solid Tumors, Ovarian Cancer	626		clinicaltrials.gov
March 3, 2026	NCT07446049	A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the...	Convalife (Shanghai) Co., Ltd.	Phase 2	Not yet recruiting	Locally Advanced or Metastatic Solid Tumors, PTEN Loss or Low Expression	180		clinicaltrials.gov
March 3, 2026	NCT07444814	Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors	Whitehawk Therapeutics, Inc.	Phase 1	Recruiting	Endometrial Cancer, Ovarian Cancer, Ovarian Cancer Metastatic, Ovarian Cancer Metastatic Recurrent, Non-squamous EGFR...	226	United States	clinicaltrials.gov
February 27, 2026	NCT07435623	Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study	Tata Memorial Hospital	Observational	Recruiting	Endometrial Cancer, Cervix Cancer	300	India	clinicaltrials.gov
February 24, 2026	NCT07429799	An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling Device	Ellele Health	Not applicable	Not yet recruiting	Ovarian Cancer, Endometrial Cancer	300		clinicaltrials.gov
February 19, 2026	NCT07419841	A Phase 1 Study of the Safety and Tolerability of CTX-10726	Compass Therapeutics	Phase 1	Recruiting	Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC), Endometrial Cancer, Renal Cell Carcinoma (RCC)	70	United States	clinicaltrials.gov
February 12, 2026	NCT07407959	Screening and Staging of Benign vs Malignant Pelvic Abnormalities	Mayo Clinic	Observational	Recruiting	Endometrial Carcinoma, Prostate Carcinoma	60	United States	clinicaltrials.gov
February 12, 2026	NCT07406087	Navigation Intervention for Adolescent and Young Adult Cancer Survivors	Kaiser Permanente	Not applicable	Recruiting	Breast Cancer, Ovarian Cancer, Cervical Cancer, Testicular Cancer, Colon Rectal Cancer, Melanoma (Skin Cancer)...	25	United States	clinicaltrials.gov
February 10, 2026	NCT07400835	Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and...	University of Aarhus	Observational	Recruiting	Postmenopausal Bleeding	600	Denmark	clinicaltrials.gov
February 9, 2026	NCT07397624	Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer	Centro di Riferimento Oncologico - Aviano	Observational	Recruiting	Endometrial Cancer	74	Italy	clinicaltrials.gov
February 3, 2026	NCT07383506	A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors	Cogent Biosciences, Inc.	Phase 1	Recruiting	PIK3CA Mutations, Advanced Solid Tumors, Adult, Endometrial Cancer, HR Positive/HER-2 Negative Breast Cancer, HER2-low...	90	United States	clinicaltrials.gov
February 3, 2026	NCT07382583	Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention...	M.D. Anderson Cancer Center	Observational	Recruiting	Levonorgestrel, Intrauterine Systems, Prevention, Endometrial Cancer	270	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	10	August 4, 2026
GlaxoSmithKline	8	October 6, 2026
AstraZeneca	8	August 15, 2025
Peking University People's Hospital	6	October 16, 2026
Mayo Clinic	6	June 23, 2026
Memorial Sloan Kettering Cancer Center	5	January 6, 2026
UNC Lineberger Comprehensive Cancer Center	4	October 9, 2026
European Institute of Oncology	4	September 11, 2026
National Cancer Institute, Naples	4	April 13, 2026
Women's Hospital School Of Medicine Zhejiang University	3	October 27, 2026
Rutgers, The State University of New Jersey	3	June 11, 2026
Peking Union Medical College Hospital	3	December 23, 2025
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	2	October 28, 2026
Guizhou Provincial People's Hospital	2	October 23, 2026
Merck Sharp & Dohme LLC	2	October 13, 2026
University College, London	2	September 21, 2026
Asan Medical Center	2	September 16, 2026
Advenchen Pharmaceuticals, LLC.	2	September 10, 2026
Sutro Biopharma, Inc.	2	September 8, 2026
Tongji Hospital	2	August 24, 2026

By phase

Phase	New trials	Latest
Not applicable	69	November 4, 2026
Observational	64	October 23, 2026
Phase 2	41	October 28, 2026
Phase 1	35	October 15, 2026
Phase 1/2	24	November 2, 2026
Phase 3	15	October 9, 2026
Phase 4	6	June 17, 2026
Early phase 1	5	January 5, 2026
Phase 2/3	2	January 6, 2026

By country

Country	New trials	Latest
United States	103	November 2, 2026
China	52	October 26, 2026
Italy	35	September 11, 2026
Spain	24	September 24, 2026
Australia	18	June 3, 2026
South Korea	17	September 16, 2026
France	16	December 29, 2025
Canada	15	October 13, 2026
Japan	15	July 6, 2026
Turkey (Türkiye)	13	October 20, 2026
Germany	13	December 29, 2025
Belgium	10	October 28, 2026
Poland	10	October 20, 2026
United Kingdom	10	October 16, 2026
Denmark	9	February 10, 2026
Taiwan	8	May 11, 2026
Finland	6	May 18, 2026
Brazil	6	December 16, 2025
Netherlands	6	October 9, 2025
Greece	5	January 5, 2026
Israel	5	December 16, 2025
Austria	5	December 3, 2025
Singapore	5	December 3, 2025
Czechia	4	January 26, 2026
Argentina	4	December 16, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.